Medical and Pharmaceutical Phase Scientific International advances urine biopsy tech with $34M fundraising round The company has gained strong market traction by launching over 30 diagnostic products across multiple health categories Joseph Morton3 days ago
Health & Wellness ‘Give a Breath’ 5K run raises lung cancer awareness in Canadian cities next month Ottawa and Calgary are new participants this year Rowan DunneMay 22, 2025
Medical and Pharmaceutical International lung cancer screening market poised for steady growth: 2025 report It will be worth over US$1.3 billion more than its current valuation by 2029, The Business Research Company says Rowan DunneMay 9, 2025
Medical and Pharmaceutical Breath Diagnostics gives the public the chance to join the fight against cancer Regulation crowdfunding allows a startup or private company to reach out directly to the public for support Joseph MortonMay 7, 2025
AI and Autonomy Alibaba Group gets FDA nod for cancer detection tool The tool can effectively detect early-stage cancers in asymptomatic patients Joseph MortonApril 24, 2025
AI and Autonomy Ainos introduces breath sensing equipment to robots in Japan System digitizes and identifies a wide range of volatile organic compounds (VOC), which are compiled into a SmellID Joseph MortonApril 23, 2025
Medical and Pharmaceutical Alarming CT radiation study highlights need for alternative diagnostic tools University of California researchers have determined that these machines can cause 1 out of every 20 new cancer cases Rowan DunneApril 15, 2025
Medical and Pharmaceutical How could a simple blood test could eliminate tumour biopsies? The company has received support from the Centre of Expertise in Advanced Materials and Sustainability and Innovate UK Joseph MortonApril 15, 2025
Medical and Pharmaceutical Median Technologies clears hurdle on the way to regulatory acceptance in EU and US The company has met a key requirement for regulatory submissions in the US and Europe Joseph MortonApril 3, 2025
Medical and Pharmaceutical Corcept Therapeutics shares double on solid Phase 3 results for ovarian cancer treatment Relacorilant is designed to address disorders linked to the stress hormone cortisol Joseph MortonMarch 31, 2025